Back
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Vs. United Therapeutics Corp. Industry Stock Comparison
Buy
71
GVUS
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF
Last Price:
$54.61
Seasonality Move:
1.15%
Buy
59
UTHR
United Therapeutics Corp.
Last Price:
$507.08
Seasonality Move:
3.94%
Buy
71
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF (GVUS)
is a Buy
Is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF a Buy, Sell or Hold?
-
The current Goldman Sachs MarketBeta Russell 1000 Value Eq ETF [GVUS] share price is $54.61. The Score for GVUS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
GVUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
United Therapeutics Corp. (UTHR)
is a Buy
Is United Therapeutics Corp. a Buy, Sell or Hold?
-
The current United Therapeutics Corp. [UTHR] share price is $514.64. The Score for UTHR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GVUS Stock Price Chart
What is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF's stock price today?
-
The Goldman Sachs MarketBeta Russell 1000 Value Eq ETF share price today is $54.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVUS is experiencing slight buying pressure.
UTHR Stock Price Chart
What is United Therapeutics Corp.'s stock price today?
-
The United Therapeutics Corp. share price today is $514.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
GVUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 61.39 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.72 - 54.5) | Buy |
| Bollinger Bands (100): | (51.26 - 53.46) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 134.97 | Buy |
| Relative Strength Index (14 RSI): | 68.66 | Buy |
| Chaikin Money Flow: | 117288 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (476.78 - 504.78) | Buy |
| Bollinger Bands (100): | (358.64 - 486.32) | Buy |
GVUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.26 | Buy |
| 20-day SMA: | 54.01 | Buy |
| 50-day SMA: | 53.09 | Buy |
| 200-day SMA: | 50.36 | Buy |
| 8-day EMA: | 54.28 | Buy |
| 20-day EMA: | 53.91 | Buy |
| 50-day EMA: | 53.23 | Buy |
| 200-day EMA: | 51.08 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 509.28 | Buy |
| 20-day SMA: | 494.02 | Buy |
| 50-day SMA: | 467.16 | Buy |
| 200-day SMA: | 361.18 | Buy |
| 8-day EMA: | 399.28 | Buy |
| 20-day EMA: | 231.39 | Buy |
| 50-day EMA: | 109.35 | Buy |
| 200-day EMA: | 29.84 | Buy |
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Earnings Growth & GVUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
United Therapeutics Corp. Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $1.85 per share.
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Corp. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||